Abbott Laboratories (ABT)

Total Non-Current Assets

$84.70B

Quarterly · Period ending: · USD

ABT logo

ABT Total Non-Current Assets

Latest reported$84.70B
ABT Quarterly Non-Current Assets ($1.79B → $84.70B)
High-resolution chart · PNG

ABT total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
84,698,000,000
84,921,000,000
60,717,000,000
59,342,000,000
59,531,000,000
58,295,000,000
57,758,000,000
50,554,000,000
49,898,000,000
50,091,000,000
50,544,000,000
49,426,000,000
49,849,000,000
49,417,000,000
49,214,000,000
47,956,000,000
49,246,000,000
50,578,000,000
50,957,000,000
50,303,000,000
50,642,000,000
50,968,000,000
52,107,000,000
51,653,000,000
51,555,000,000
51,279,000,000
52,220,000,000
52,420,000,000
53,232,000,000
53,201,000,000
52,541,000,000
53,441,000,000
54,293,000,000
55,944,000,000
56,103,000,000
50,871,000,000
51,168,000,000
51,558,000,000
28,235,000,000
26,519,000,000
26,843,000,000
27,231,000,000
27,092,000,000
25,831,000,000
22,994,000,000
23,110,000,000
26,014,000,000
26,050,000,000
23,217,000,000
23,731,000,000
23,706,000,000
24,383,528,000
23,072,222,000
23,589,745,000
35,912,361,000
35,993,494,000
35,602,298,000
36,813,670,000
36,508,119,000
36,533,760,000
37,872,063,000
38,004,231,000
37,144,737,000
37,926,200,000
33,466,095,000
35,667,944,000
29,102,732,000
28,430,978,000
28,001,641,000
27,429,703,000
25,376,645,000
26,526,279,000
27,116,551,000
26,065,832,000
25,671,191,000
24,783,713,000
24,814,313,000
24,781,900,000
24,896,289,000
23,229,294,000
24,163,482,000
17,922,668,000
17,755,175,000
17,842,280,000
18,153,964,000
18,506,091,000
18,033,009,000
17,348,223,000
17,183,221,000
17,110,511,000
16,424,927,000
15,893,891,000
16,176,058,000
15,451,134,000
15,137,330,000
15,176,206,000
15,043,056,000
14,690,255,000
14,877,234,000
14,548,498,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.